Literature DB >> 9315562

Three-dimensional echocardiographic estimation of infarct mass based on quantification of dysfunctional left ventricular mass.

J Yao1, Q L Cao, N Masani, A Delabays, G Magni, P Acar, C Laskari, N G Pandian.   

Abstract

BACKGROUND: Two-dimensional echocardiography is useful for estimating the extent of infarct-related wall motion abnormalities. Such estimation, however, is based on a few selected views and extrapolated for the whole left ventricle (LV). This approach does not provide us with the actual amount of dysfunctional myocardium. Volume-rendered three-dimensional echocardiography (3DE) might overcome these limitations. In this study we explored (1) how well volume-rendered 3DE delineates regional dysfunction of the infarcted LV and (2) how well dysfunctional myocardial mass quantified by 3DE reflects the actual anatomic infarct mass. METHODS AND
RESULTS: 3DE was performed before and 3 hours after coronary occlusion in 16 dogs. With the LV viewed in equidistant short-axis slices, the region of dysfunction was demarcated, and the dysfunctional myocardial mass was derived from this. With triphenyltetrazolium chloride staining, anatomic infarct regions were delineated, dissected, and weighed. The anatomic infarct mass was 16.3+/-7.7 g (mean+/-SD) (range, 6.4 to 31.4 g); the dysfunctional mass estimated by 3DE was 17.4+/-9.1 g (range, 5.2 to 39.0 g). The mean difference was 1.0 g. The correlation between dysfunctional mass (y) and infarct mass (x) was y=l.lx-0.6, r=.93 (P<.0001). The percentage of LV involved in infarction was 18.2+/-5.8% (range, 9.1% to 26.1%); the percentage of LV involved in regional dysfunction was 18.3+/-6.9% (range, 7.9% to 31.2%). The mean difference was 0.1%. The correlation between percentage of LV involved in infarction (x) and percentage of LV involved in dysfunction (y) was y=1.0x-1.1, r=.92 (P<.0001).
CONCLUSIONS: Volume-rendered 3DE crisply displays regional dysfunction of infarcted LV. 3DE-measured dysfunctional mass accurately reflects the anatomic infarct mass.

Entities:  

Mesh:

Year:  1997        PMID: 9315562     DOI: 10.1161/01.cir.96.5.1660

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Determination of left ventricular mass by three-dimensional echocardiography: in vitro validation of a novel quantification method using multiple equi-angular rotational planes for rapid measurements.

Authors:  Claudius Teupe; Masaaki Takeuchi; Jiefen Yao; Natesa Pandian
Journal:  Int J Cardiovasc Imaging       Date:  2002-06       Impact factor: 2.357

Review 2.  Left ventricular assessment using real time three dimensional echocardiography.

Authors:  L Sugeng; L Weinert; R M Lang
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

3.  Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man.

Authors:  M L Chuang; R A Beaudin; M F Riley; M G Mooney; W J Mannin; P S Douglas; M G Hibberd
Journal:  Int J Card Imaging       Date:  2000-10

4.  Quantification of murine myocardial infarct size using 2-D and 4-D high-frequency ultrasound.

Authors:  Melissa M Dann; Sydney Q Clark; Natasha A Trzaskalski; Conner C Earl; Luke E Schepers; Serena M Pulente; Ebonee N Lennord; Karthik Annamalai; Joseph M Gruber; Abigail D Cox; Ilka Lorenzen-Schmidt; Richard Seymour; Kyoung-Han Kim; Craig J Goergen; Erin E Mulvihill
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-01-07       Impact factor: 4.733

Review 5.  Current cardiac imaging techniques for detection of left ventricular mass.

Authors:  Aksuyek S Celebi; Hulya Yalcin; Fatih Yalcin
Journal:  Cardiovasc Ultrasound       Date:  2010-06-01       Impact factor: 2.062

6.  Quantitative three-dimensional wall motion analysis predicts ischemic region size and location.

Authors:  Susan L Herz; Takuya Hasegawa; Amgad N Makaryus; Katherine M Parker; Shunichi Homma; Jie Wang; Jeffrey W Holmes
Journal:  Ann Biomed Eng       Date:  2010-01-13       Impact factor: 3.934

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.